Nevro Corp(NVRO) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. It also offers Senza II system and Senza Omnia system products for chronic pain. The company's solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. Nevro Corp. sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was founded in 2006 and is headquartered in Redwood City, California.

Current Price

$144.88

RSI

8.365

Beta:

0.9895

December 31, 2020
86.5M
315M
-9.4M

1.307 %
-19.799 %
99.881 %
-23.695 %

$362,048,000
$390,255,000
$387,289,000
$326,674,000
$228,504,000
$69,606,000
-7.228 %
0.766 %
18.555 %
42.962 %
228.282 %

$-82,197,000
$-102,087,000
$-48,437,000
$-35,250,000
$-30,155,000
$-66,265,000
19.483 %
-110.762 %
-37.410 %
-16.896 %
54.493 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.